Thrombotic microangiopathy during carfilzomib use: case series in Singapore - Top-Institutions - MDSpire

Thrombotic microangiopathy during carfilzomib use: case series in Singapore

By
Y Chen
M Ooi
S F Lim
A Lin
J Lee
C Nagarajan
C Phipps
Y S Lee
N F Grigoropoulos
Z Lao
S Surendran
E M Teh
Y T Goh
W J Chng
S K Gopalakrishnan
July 29, 2016
0 min

Blood Cancer Journal

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

#1

Mayo Clinic

Rochester, MN
Key Differentiators
- Hematology
- Oncology
- Multiple Myeloma Research
#2

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Hematology
- Oncology
- Multiple Myeloma
#3

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Hematology
- Oncology
- Myeloma Research
#4

Singapore General Hospital

Singapore, N/A
Key Differentiators
- Hematology
- Oncology
#5

University of Texas MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Hematology
- Oncology
- Multiple Myeloma

Original Source(s)

Blood Cancer Journal

Thrombotic microangiopathy during carfilzomib use: case series in Singapore

by Y Chen, M Ooi, S F Lim, A Lin, J Lee, C Nagarajan, C Phipps, Y S Lee, N F Grigoropoulos, Z Lao, S Surendran, E M Teh, Y T Goh, W J Chng, S K Gopalakrishnan
July 29, 2016

Related Content

Blood Cancer Journal (Nature Portfolio)

Enterocolitis Associated with Immune Effector Cells Following BCMA-Targeted CAR T-Cell Therapy: Findings from a Multicenter Case Series

Frontiers In Cardiovascular Medicine

Short-term cardiotoxicity and early echocardiographic changes following autologous hematopoietic stem cell transplantation: a single-center retrospective analysis

Frontiers In Medicine

Hematological abnormalities in clinically diagnosed non-alcoholic steatohepatitis: prevalence, clinical correlates, and fibrosis risk in a case–control study from Qatar